Age-Related Differences in Rejection Rates, Infections, and Tacrolimus Exposure in Pediatric Kidney Transplant Recipients in the CERTAIN Registry

This is the largest study to date in European pKTRs on a tacrolimus-based immunosuppressive regimen, and it shows important age-related differences in rejection rates, infection episodes, as well as tacrolimus exposure and clearance. This data suggests that immunosuppressive therapy in pKTRs should be tailored and personalized according to the age-specific risk profiles of this heterogeneous patient population. The data may serve as a benchmark for future studies with novel immunosuppressive drugs.

Authors

Institutions

Publication Details

Journal
Kidney International Reports
Published
2024-09-02
DOI
https://doi.org/10.1016/j.ekir.2024.08.025
Citations
11
Primary Topic
Renal Transplantation Outcomes and Treatments
Type
article
Field-Weighted Citation Impact
5.59

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Age-Related Differences in Rejection Rates, Infections, and Tacrolimus Exposure in Pediatric Kidney Transplant Recipients in the CERTAIN Registry

Alexander Fichtner, Licia Peruzzi, Birgitta Kranz, Jun Oh et al.
11 citations
Kidney International Reports
Renal Transplantation Outcomes and Treatments
5.59
article

Age-Related Differences in Rejection Rates, Infections, and Tacrolimus Exposure in Pediatric Kidney Transplant Recipients in the CERTAIN Registry

Alexander Fichtner, Licia Peruzzi, Birgitta Kranz, Jun Oh, Atif Awan, Lutz T. Weber, Anja Büscher, Kai Krupka, Isabella Guzzo, Jon Jin Kim, Britta Höcker, Elisa Benetti, Lars Pape, Mieczysław Litwin, Mohan Shenoy, Manuel Feißt, Ali Düzova, Sara Testa, Maral Baghai Arassi, Jakub Zieg, Burkhard Tönshoff
article en
11 citations

Abstract

This is the largest study to date in European pKTRs on a tacrolimus-based immunosuppressive regimen, and it shows important age-related differences in rejection rates, infection episodes, as well as tacrolimus exposure and clearance. This data suggests that immunosuppressive therapy in pKTRs should be tailored and personalized according to the age-specific risk profiles of this heterogeneous patient population. The data may serve as a benchmark for future studies with novel immunosuppressive drugs.

Kidney International ReportsVol. 9(11)
Nottingham University Hospitals NHS Trust (GB), University of Padua (IT), Universität Hamburg (DE), University of Cologne (DE), Charles University (CZ), Heidelberg University (DE), University Hospital Heidelberg (DE), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT), Temple Street Children's University Hospital (IE), Azienda Ospedaliera Citta' della Salute e della Scienza di Torino (IT), University Hospital in Motol (CZ), Zimmer Biomet (Germany) (DE), University Hospital Münster (DE), University Medical Center Hamburg-Eppendorf (DE), Children's Memorial Health Institute (PL), Essen University Hospital (DE), Bambino Gesù Children's Hospital (IT), European Molecular Biology Laboratory (DE), Istituti di Ricovero e Cura a Carattere Scientifico (IT), European Molecular Biology Laboratory (DE), University Hospital Cologne (DE), Royal Manchester Children's Hospital (GB), Hacettepe University (TR)
Astellas Pharma
Openalex Percentile: Top 3%
Renal Transplantation Outcomes and Treatments
5.59
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.